FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022139626> ?p ?o ?g. }

• W2022139626 endingPage "30846" @default.
• W2022139626 startingPage "30843" @default.
• W2022139626 abstract "The expressions and activities of several CCAAT/enhancer-binding proteins (C/EBP) isoforms fluctuate in the regenerating liver. The physiological implications of these variations in C/EBP function remain poorly characterized in the setting of regeneration. However, lessons learned in various hepatocyte cell lines and by studying primary hepatocytes from transgenic C/EBPα-deficient mice suggest that the C/EBP isoforms are likely to influence proliferation, differentiated gene expression, and survival in mature, adult hepatocytes. In addition, these factors are potentially important modulators of liver nonparenchymal cell genes, including those that encode matrix molecules and growth factors that are required for successful liver regeneration. The possibility that members of the C/EBP family of transcription factors actively participate in many aspects of the regenerative response to liver injury is strengthened by growing evidence that many hepatocyte mitogens and co-mitogens regulate C/EBP activity. Furthermore, the C/EBPs themselves appear to regulate the expression of some of these growth regulators. The expressions and activities of several CCAAT/enhancer-binding proteins (C/EBP) isoforms fluctuate in the regenerating liver. The physiological implications of these variations in C/EBP function remain poorly characterized in the setting of regeneration. However, lessons learned in various hepatocyte cell lines and by studying primary hepatocytes from transgenic C/EBPα-deficient mice suggest that the C/EBP isoforms are likely to influence proliferation, differentiated gene expression, and survival in mature, adult hepatocytes. In addition, these factors are potentially important modulators of liver nonparenchymal cell genes, including those that encode matrix molecules and growth factors that are required for successful liver regeneration. The possibility that members of the C/EBP family of transcription factors actively participate in many aspects of the regenerative response to liver injury is strengthened by growing evidence that many hepatocyte mitogens and co-mitogens regulate C/EBP activity. Furthermore, the C/EBPs themselves appear to regulate the expression of some of these growth regulators. CCAAT/enhancer-binding protein 70% (partial) hepatectomy tumor necrosis factor interleukin inducible nitric oxide synthase nitric oxide hepatocyte growth factor. Liver regeneration is a complex physiological response to liver injury during which the surviving, mature hepatocytes and liver nonparenchymal cells proliferate to reconstitute the pre-morbid mass of the damaged organ. The liver is one of the few tissues in adult vertebrates that retains the capacity for regeneration. However, such compensatory hyperplasia requires careful orchestration to assure that vital liver-specific functions are preserved while hepatocytes, which generally do not proliferate in adult animals, replicate. The study of organisms that are as divergent as urodeles and humans has identified common, fundamental processes that are required for the regeneration of any tissue. This work indicates that regeneration occurs only if injury-related changes in the local extracellular environment motivate differentiated, but proliferation-competent, cells to reenter the cell cycle while the normal homeostatic mechanisms that couple cell cycle reentry to cell death are suspended (1Brockes J.P. Science. 1997; 276: 81-87Crossref PubMed Scopus (389) Google Scholar, 2Michalopoulos G.K. DeFrances M.C. Science. 1997; 276: 60-66Crossref PubMed Scopus (2870) Google Scholar, 3Stocum D.L. Science. 1997; 276: 15Crossref PubMed Scopus (29) Google Scholar). Although much has been learned about the mechanisms that regulate hepatic regeneration, many aspects of the process remain poorly understood. CCAAT/enhancer-binding proteins (C/EBPs)1 are known to play important roles in regulating the expression of multiple hepatocyte-specific genes (4Lekstrom-Himes J. Xanthopoulos K.G. J. Biol. Chem. 1998; 273: 28545-28548Abstract Full Text Full Text PDF PubMed Scopus (685) Google Scholar). These transcription factors also help to control hepatocyte progression through the cell cycle (5Hendricks-Taylor L.R. Darlington G.J. Nucleic Acids Res. 1995; 23: 4726-4733Crossref PubMed Scopus (112) Google Scholar, 6Timchenko N.A. Wilde M. Nakanishi M. Smith J.R. Darlington G.J. Genes Dev. 1996; 10: 804-815Crossref PubMed Scopus (345) Google Scholar). Thus, the C/EBPs are likely to be important targets for regulation during liver regeneration. Consistent with this concept, variations in the expression of C/EBP mRNAs, proteins, and DNA binding activities have been documented during liver regeneration. C/EBPα is the predominant C/EBP isoform that is expressed by adult hepatocytes in healthy livers. During the initial 24 h after 70% (partial) hepatectomy (PH), levels of C/EBPα mRNA and protein decline transiently. This is associated with decreased binding activity of C/EBPα homodimers in gel mobility shift assays. Decreases in C/EBPα are preceded by the induction of other C/EBP isoforms. The level of C/EBPβ and C/EBPδ mRNAs, proteins, and DNA binding activities increases in the early pre-replicative period following PH and returns to base line as hepatocytes enter S phase (7Mischoulon D. Rana B. Bucher N.L. Farmer S.R. Mol. Cell. Biol. 1992; 12: 2553-2560Crossref PubMed Google Scholar, 8Flodby P. Antonson P. Barlow C. Blanck A. Porsch-Hallstrom I. Xanthopoulos K.G. Exp. Cell Res. 1993; 208: 248-256Crossref PubMed Scopus (71) Google Scholar, 9Diehl A.M. Yang S.Q. Hepatology. 1994; 19: 447-456PubMed Google Scholar, 10Rana B. Xie Y. Mischoulon D. Bucher N.L.R. Farmer S.R. J. Biol. Chem. 1995; 270: 18123-18132Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar). The importance of these reciprocal variations in C/EBPα and other C/EBP isoforms in regulating hepatocyte proliferation during liver regeneration has been debated. Present controversy stems from an apparently poor correlation between the induction of C/EBPβ DNA binding activity and hepatocyte proliferation in transgenic mice strains with disruption of certain cytokines or cytokine receptors. Mice homozygous for a deletion in the gene for the type 1 TNF receptor have extremely limited hepatocyte proliferation after PH and yet exhibit apparently normal induction of total C/EBP DNA binding activity during the early pre-replicative period (11Yamada Y. Kirillova I. Peschon J.J. Fausto N. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1441-1446Crossref PubMed Scopus (828) Google Scholar). In contrast, transgenic mice lacking the gene for type 2 TNF receptors demonstrate normal hepatocyte proliferation after PH but decreased induction of C/EBPβ DNA binding activity (12Yamada Y. Webber E.M. Kirillova I. Peschon J.J. Fausto N. Hepatology. 1998; 28: 959-970Crossref PubMed Scopus (214) Google Scholar). Furthermore, liver regeneration is severely inhibited in IL-6-null mice, although these animals exhibit normal induction of C/EBPβ mRNAs after PH (13Cressman D.E. Greenbaum L.E. DeAngelis R.A. Ciliberto G. Furth E.E. Poli V. Taub R. Science. 1996; 274: 1379-1383Crossref PubMed Scopus (1305) Google Scholar). However, because C/EBP function is regulated, to a large extent, by post-transcriptional modifications of the C/EBPs themselves, as well as by their interactions with specific dimerization partners (14Poli V. Mancini F.P. Cortese R. Cell. 1990; 63: 643-653Abstract Full Text PDF PubMed Scopus (455) Google Scholar, 15Descombes P. Schibler U. Cell. 1991; 67: 569-579Abstract Full Text PDF PubMed Scopus (857) Google Scholar, 16LeClair K.P. Blanar M.A. Sharp P.A. Proc. Natl. Acad. Sci. U. S. A. 1992; 90: 4679-4683Google Scholar, 17Matsusaka T. Fujikawa K. Nishio Y. Mukaida N. Matsushima K. Kishimoto T. Akira S. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 10193-10197Crossref PubMed Scopus (873) Google Scholar, 18Yin M. Yang S.Q. Lin H.Z. Lane M.D. Chatterjee S. Diehl A.M. J. Biol. Chem. 1996; 271: 17974-17978Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar, 19Wegner M. Cao Z. Rosenfeld M.G. Science. 1992; 256: 370-373Crossref PubMed Scopus (306) Google Scholar, 20Trautwein C. Caelles C. vander Geer P. Hunter T. Karin M. Chojkier M. Nature. 1993; 364: 544-547Crossref PubMed Scopus (293) Google Scholar, 21Chinery R. Brockman J.A. Dransfield D.T. Coffey R.J. J. Biol. Chem. 1997; 272: 30356-30361Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar), the former observations do not preclude an important role for the C/EBPs as regulators of hepatocyte proliferation during liver regeneration. Indeed, other evidence supports the biological importance of the C/EBPs as physiologically relevant regulators of hepatocyte proliferation. Transgenic mice with a deleted C/EBPα gene have increased hepatocyte proliferation at birth (22Wang N.-D. Finegold M.J. Bradley A. Ou C.H. Abdelsayed S.V. Wilde M.D. Taylor R. Wilson D.R. Darlington G.J. Science. 1995; 269: 1108-1112Crossref PubMed Scopus (830) Google Scholar, 23Flodby P. Barlow C. Kylefjord H. Ahrlund-Richter L. Xanthopoulos K.G. J. Biol. Chem. 1996; 271: 24753-24760Abstract Full Text Full Text PDF PubMed Scopus (248) Google Scholar). Because these animals do not survive long enough to permit evaluation of their response to PH, whether or not C/EBPα deletion enhances hepatocyte proliferation during liver regeneration has not been tested. However, hepatocytes isolated from these mice do have increased proliferative activity in culture (24Soriano H.E. Kang D.C. Finegold M.J. Hicks M.J. Wang N.D. Harrison W. Darlington G.J. Hepatology. 1998; 27: 332-340Crossref PubMed Scopus (43) Google Scholar). Conversely, enforced overexpression of C/EBPα has been shown to inhibit proliferation in several different hepatocyte cell lines (5Hendricks-Taylor L.R. Darlington G.J. Nucleic Acids Res. 1995; 23: 4726-4733Crossref PubMed Scopus (112) Google Scholar,25Diehl A.M. Johns D. Yang S.Q. Lin H.Z. Yin M. Lawrence J. J. Biol. Chem. 1996; 271: 7343-7350Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar, 26Watkins P.J. Condreay J.P. Huber E. Jacombs S.J. Adams D.J. Cancer Res. 1996; 56: 1063-1067PubMed Google Scholar). Thus, it seems reasonable to conclude that changes in the relative amounts (or activities) of C/EBPα and other C/EBP isoforms influence the proliferative activity of hepatocytes during liver regeneration. However, because of the complexity of the C/EBP family of transcription factors, the multiple extracellular signals that regulate C/EBP activities, and the fact that hepatocytes co-express several different C/EBP isoforms, the role of each C/EBP family member in the regulation of hepatocyte proliferation during liver regeneration remains uncertain. Now that transgenic mice have been developed with targeted disruption of different C/EBP genes, it will be possible to use these mice to delineate the relative importance of different C/EBP isoforms as regulators of the hepatocyte proliferative responsein vivo. Indeed, Greenbaum and colleagues have reported preliminary evidence that C/EBPβ knock-out mice exhibit impaired hepatocyte proliferation and decreased liver regeneration after PH. 2L. Greenbaum, FASEB Conference, Snomass, CO, July, 1998. There are several mechanisms by which the C/EBPs may regulate hepatocyte proliferation. C/EBPα is known to stabilize p21/WAF, a protein that inhibits transition from the pre-replicative (G1) period into S phase (5Hendricks-Taylor L.R. Darlington G.J. Nucleic Acids Res. 1995; 23: 4726-4733Crossref PubMed Scopus (112) Google Scholar). Because induction of C/EBPβ and C/EBPδ during the early pre-replicative period may inhibit subsequent C/EBPα activity by repressing C/EBPα gene expression, reciprocal variations in C/EBP isoforms could release hepatocytes from C/EBPα-mediated cell cycle arrest. There is also some evidence that C/EBPβ may positively regulate the expression of genes that promote cell cycle progression. For example, C/EBP consensus sequences have been identified in the regulatory regions of cyclin D2 (27Jun D.Y. Kim M.K. Kim I.G. Kim Y.H. Mol. Cells. 1997; 7: 537-543PubMed Google Scholar) and cyclin A (28Kramer A. Carstens C.B. Fahl W.E. J. Biol. Chem. 1996; 271: 6579-6582Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar) and may also interact with the retinoblastoma protein (RB) (29Chen P.-L. Riley D.J. Chen Y. Lee W.-H. Genes Dev. 1996; 10: 2794-2804Crossref PubMed Scopus (390) Google Scholar). In addition to promoting hepatocyte proliferation, changes in the relative expression of different C/EBP isoforms may affect global changes in hepatocyte gene expression that permit these cells to survive the “stress” of regeneration. For example, C/EBPβ and -δ are important in modulating the expression of various acute phase response genes, including those such as inducible nitric oxide synthase (iNOS) (30Goldring C.E.P. Reveneau S. Algarte M. Jeannin J.-F. Nucleic Acids Res. 1996; 24: 1682-1687Crossref PubMed Scopus (86) Google Scholar, 31Kinugawa K.-i. Shimizu T. Yao A. Kohmoto S. Serizawa T. Takahashi T. Circ. Res. 1997; 81: 911-921Crossref PubMed Scopus (102) Google Scholar, 32Hecker M. PreiB C. Schini-Kerth V.B. Br. J. Pharmacol. 1997; 120: 1067-1074Crossref PubMed Scopus (53) Google Scholar), that are thought to protect hepatocytes from cytokine-mediated toxicity (33Kim Y.M. Talanian R.V. Billiar T.R. J. Biol. Chem. 1997; 272: 31138-31148Abstract Full Text Full Text PDF PubMed Scopus (796) Google Scholar, 34Bohlinger I. Leist M. Barsig J. Uhlig S. Tiegs G. Wendel A. Hepatology. 1995; 22: 1829-1837PubMed Google Scholar, 35Bautista A.P. Spitzer J.J. Am. J. Physiol. 1994; 29: G783-G788Google Scholar, 36Harbrecht B. Stadler J. Demetris A. Simmons R. Billiar T. Am. J. Physiol. 1994; 266: G1004-G1010PubMed Google Scholar, 37Horie Y. Wolf R. Granger D.N. Am. J. Physiol. 1997; 273: G1007-G1013PubMed Google Scholar). The activity of iNOS and production of nitric oxide (NO) increase in hepatocytes in the mid-late pre-replicative period following PH (38Diaz-Guerra M.J.M. Velasco M. Martin-Sanz P. Bosca L. Biochem. J. 1997; 326: 791-797Crossref PubMed Scopus (30) Google Scholar, 39Obolenskaya M. Schulze-Specking A. Plaumann B. Freudenberg N. Decker K. Biochem. Biophys. Res. Commun. 1994; 204: 1305-1311Crossref PubMed Scopus (38) Google Scholar, 40Obolenskaya M.Y. Vanin A.F. Mordvintcex P.Z. Mulsch A. Decker K. Biochem. Biophys. Res. Commun. 1994; 202: 571-576Crossref PubMed Scopus (69) Google Scholar). NO has diverse biological actions and has recently been shown to inhibit caspase 3 activation by TNFα (33Kim Y.M. Talanian R.V. Billiar T.R. J. Biol. Chem. 1997; 272: 31138-31148Abstract Full Text Full Text PDF PubMed Scopus (796) Google Scholar, 41Dimmler S. Rippmann V. Weiland U. Haendeler J. Zekher A.M. Circ. Res. 1997; 81: 970-976Crossref PubMed Scopus (344) Google Scholar). Given the pivotal role that caspase 3 plays in apoptosis (42Nicholson D.W. Ali A. Thornberry N.A. Vaillancourt J.P. Ding C.K. Gallant M. Gareau Y. Griffin P.R. Labelle M. Lazebnik Y.A. et al.Nature. 1995; 376: 37-43Crossref PubMed Scopus (3782) Google Scholar, 43Casciola-Rosen L.A. Miller D.K. Anhalt G.J. Rosen A. J. Biol. Chem. 1994; 269: 30757-30760Abstract Full Text PDF PubMed Google Scholar, 44Casciola-Rosen L.A. Nicholson D.W. Chong T. Rowan K.R. Thornberry N.A. Miller D.K. Rosen A. J. Exp. Med. 1996; 813: 1957-1964Crossref Scopus (576) Google Scholar), C/EBPβ-mediated induction of NO production may be one of the mechanisms that prevents injury-related cytokines from causing hepatocyte apoptosis in the regenerating liver. Preliminary experiments in iNOS-deficient transgenic mice support this view. 3A. M. Diehl and R. Rai, unpublished data. Although liver regeneration imposes a tremendous drain on hepatocyte ATP stores, hepatocyte necrosis is not normally increased by PH. Changes in the expression of phosphoenolpyruvate carboxykinase, glycogen synthase, and many other genes that regulate hepatic metabolism occur quickly after PH (45Mohn K.L. Laz T.M. Melby A.E. Taub R. J. Biol. Chem. 1990; 265: 21914-21921Abstract Full Text PDF PubMed Google Scholar, 46Diehl A.M. Yang S.Q. Yin M. Lin H.Z. Nelson S. Bagby G. Hepatology. 1995; 22: 252-261PubMed Google Scholar, 47Greenbaum L.E. Cressman D.E. Haber B.A. Taub R. J. Clin. Invest. 1995; 96: 1351-1365Crossref PubMed Scopus (83) Google Scholar). C/EBPβ and -δ are important transcriptional regulators of many of the genes that are involved in metabolism (48Nishiyori A. Tashiro H. Kimura A. Akagi K. Yamamura K. Mori M. Takiguchi M. J. Biol. Chem. 1994; 269: 1323-1331Abstract Full Text PDF PubMed Google Scholar, 49Patel Y.M. Yun J.S. Liu J. McGrane M.M. Hanson R.W. J. Biol. Chem. 1994; 269: 5619-5628Abstract Full Text PDF PubMed Google Scholar, 50Trautwein C. Rakemann T. Pietrangelo A. Plumpe J. Montosi G. Manns M.P. J. Biol. Chem. 1996; 271: 22262-22270Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar). As such, these transcription factors modify hepatocyte substrate utilization to assure energy homeostasis during the period of intense proliferative activity. Because failure to meet the increased ATP requirements during regenerative growth could lead to hepatocyte ATP depletion and necrosis, successful regulation of C/EBP activity may be important for thwarting hepatocyte necrosis during the regenerative response to injury. Successful regeneration of the liver requires much more than the proliferation of hepatocytes. Cells that form supporting structures, such as bile ducts and blood vessels, must also replicate. In addition, new matrix must be deposited to provide a scaffolding for the “rebuilding” effort. Furthermore, evidence that hepatocyte proliferation is driven largely by factors that are produced within the regenerating liver implies that de novo synthesis of autocrine and paracrine growth regulatory factors must follow liver injury (2Michalopoulos G.K. DeFrances M.C. Science. 1997; 276: 60-66Crossref PubMed Scopus (2870) Google Scholar). The importance of the C/EBPs in regulating these aspects of the hepatic regenerative response has barely been evaluated. Workers in the field of hepatic fibrogenesis have long recognized that inflammation initiates fibrosis. The molecular basis for this observation is being discovered. Injury-related cytokines, such as TNFα and IL-6, and oxidant stress are known to induce several transcription factors, including C/EBPβ, that activate transcription of the type I collagen gene in stellate cells (2Michalopoulos G.K. DeFrances M.C. Science. 1997; 276: 60-66Crossref PubMed Scopus (2870) Google Scholar). C/EBP sites have also been identified in the promoters of metalloproteinases (51Doyle G.A.R. Pierce R.A. Parks W.C. J. Biol. Chem. 1997; 272: 11840-11849Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). Thus, the C/EBPs are likely to regulate matrix production and remodeling by hepatic nonparenchymal cells during liver regeneration. Stellate cells are also the principal source of the hepatocyte mitogen, HGF, in the regenerating liver (2Michalopoulos G.K. DeFrances M.C. Science. 1997; 276: 60-66Crossref PubMed Scopus (2870) Google Scholar). The regulatory regions of the HGF gene contain C/EBP consensus motifs (52Jiang J.G. Zarnegar R. Mol. Cell. Biol. 1997; 17: 5758-5770Crossref PubMed Scopus (52) Google Scholar), and recently, C/EBPβ was shown totrans-activate HGF gene expression. Furthermore, recombinant TNFα induces a dose-dependent increase in IL-6 expression in primary stellate cell cultures. This is followed by increased C/EBPβ DNA binding activity and induction of HGF mRNA expression. 4R. Rai, F. Anania, S. Q. Yang, H. Z. Lin, J. J. Potter, and A. M. Diehl, submitted for publication. These observations suggest that the C/EBPs play a role in regulating the production of paracrine growth factors in the regenerating liver. Definitive proof of this concept awaits analysis of HGF gene induction in the liver remnants of C/EBPβ knock-out mice that have been subjected to PH. Injury-related cytokines, particularly TNFα and IL-6, are now widely acknowledged to play pivotal parts in the initiation of hepatocyte proliferation after PH (11Yamada Y. Kirillova I. Peschon J.J. Fausto N. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1441-1446Crossref PubMed Scopus (828) Google Scholar, 13Cressman D.E. Greenbaum L.E. DeAngelis R.A. Ciliberto G. Furth E.E. Poli V. Taub R. Science. 1996; 274: 1379-1383Crossref PubMed Scopus (1305) Google Scholar, 54Akerman P. Cote P. Yang S.Q. McClain C. Nelson S. Bagby G.J. Diehl A.M. Am. J. Physiol. 1992; 263: G579-G585Crossref PubMed Google Scholar, 55Diehl A.M. Yin M. Fleckenstein J. Yang S.Q. Lin H.Z. Brenner D.A. Westwick J. Bagby G. Nelson S. Am. J. Physiol. 1994; 267: G552-G561PubMed Google Scholar), although the relative importance and precise roles of these factors during liver regeneration remain a topic of considerable debate. Binding sites for C/EBPβ have been identified in the promoters of a large number of cytokine genes, including TNFα, IL-1, -6, and -8, and granulocyte colony-stimulating factor (56Yan S.F. Trittto I. Pinsky D. Liao H. Huang J. Fuller G. May L. Stern D. J. Biol. Chem. 1995; 270: 11463-11471Abstract Full Text Full Text PDF PubMed Scopus (311) Google Scholar, 57Zhang Y. Rom W.N. Mol. Cell. Biol. 1993; 13: 3831-3837Crossref PubMed Google Scholar, 58Wedel A. Sulski G. Zeigler-Heitbrock H.W. Cytokine. 1996; 8: 341-355Crossref Scopus (38) Google Scholar, 59Akira S. Isshiki H. Sugita T. Tanabe O. Kinoshita S. Nishio Y. Nakajima T. Hirano T. Kishimoto T. EMBO. J. 1990; 9: 1897-1906Crossref PubMed Scopus (1204) Google Scholar). Transfection studies with TNFα reporter gene constructs have demonstrated that C/EBPβ is much more active than C/EBPα as an inducer of TNF gene transcription. Furthermore, C/EBPβ and -δ are the predominate C/EBP isoforms in activated macrophages, which produce large amounts of TNF and TNF-inducible cytokines. Consistent with the concept that C/EBPβ is important for TNF induction, inflammation-related increases in serum TNFα concentrations are blunted in C/EBPβ-deficient transgenic mice. This observation suggests that decreased production of TNFα may contribute to the impaired liver regeneration that Greenbaum's group has noted in C/EBPβ knock-out mice. Decreases in TNFα, in turn, would be expected to influence the relative abundance of C/EBP family members in the nuclei of hepatocytes and other TNF target cells because TNF or peptide ligands that specifically activate type 1 or type 2 TNF receptors induce an almost instantaneous redistribution of preformed C/EBPβ and C/EBPδ from the cytosol into the nucleus (18Yin M. Yang S.Q. Lin H.Z. Lane M.D. Chatterjee S. Diehl A.M. J. Biol. Chem. 1996; 271: 17974-17978Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar). Although C/EBPβ was initially proposed as a potential mediator of the TNF-dependent induction of IL-6, which occurs after PH (11Yamada Y. Kirillova I. Peschon J.J. Fausto N. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1441-1446Crossref PubMed Scopus (828) Google Scholar,54Akerman P. Cote P. Yang S.Q. McClain C. Nelson S. Bagby G.J. Diehl A.M. Am. J. Physiol. 1992; 263: G579-G585Crossref PubMed Google Scholar), studies using mice homozygous for a deletion in the gene for C/EBPβ demonstrate that C/EBPβ is not essential for IL-6 induction because these mice actually develop increased circulating levels of IL-6 as they age (60Alonzi T. Gorgori G. Screpanti I. Gulino A. Poli V. Immunobiology. 1997; 198: 144-156Crossref PubMed Scopus (27) Google Scholar). Given this, it is unlikely that decreased induction of IL-6 contributes to the impaired liver regeneration that Greenbaum's group has noted in the C/EBPβ knock-out mice. Rather, these observations demonstrate that organisms have developed many mechanisms to preserve cytokine induction when any given cytokine-induced transcription factor becomes deficient. The latter may help to explain why IL-6 induction is not entirely abolished in transgenic TNF receptor type 1-null mice (11Yamada Y. Kirillova I. Peschon J.J. Fausto N. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 1441-1446Crossref PubMed Scopus (828) Google Scholar) or in rats that were pretreated with anti-TNF antibodies before PH (54Akerman P. Cote P. Yang S.Q. McClain C. Nelson S. Bagby G.J. Diehl A.M. Am. J. Physiol. 1992; 263: G579-G585Crossref PubMed Google Scholar). Similarly, because IL-6 induces C/EBPβ and C/EBPβ regulates the transcription of multiple cytokines, including TNFα, it is difficult to assure that IL-6 is the only cytokine that is deficient in transgenic mice in which the IL-6 gene has been disrupted experimentally. C/EBP function is regulated at many levels, consistent with the growing body of evidence which suggests that these factors regulate critical events that are involved in cellular proliferation, differentiation, and survival. Several hormones (e.g.insulin, glucagon, epinephrine, norepinephrine, and corticosteroids) that increase in the blood after PH (2Michalopoulos G.K. DeFrances M.C. Science. 1997; 276: 60-66Crossref PubMed Scopus (2870) Google Scholar) are known to regulate either the expression or activity of various C/EBP isoforms. For example, insulin has been shown to alter the turnover of the 40–42 kDa C/EBPα proteins, accelerating their degradation (61MacDougald O.A. Cornelius P. Liu R. Lane D.M. J. Biol. Chem. 1995; 270: 647-654Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar). Cyclic AMP is known to increase transcription of C/EBPβ and -δ (61MacDougald O.A. Cornelius P. Liu R. Lane D.M. J. Biol. Chem. 1995; 270: 647-654Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar, 62Niehof M. Manns M.P. Trautwein C. Mol. Cell. Biol. 1997; 17: 3600-3613Crossref PubMed Google Scholar, 63MacDougald O.A. Cornelius P. Lin F.-T. Chen S.S. Lane M.D. J. Biol. Chem. 1994; 269: 19041-19047Abstract Full Text PDF PubMed Google Scholar). Hence, glucagon and epinephrine, which increase adenylyl cyclase activity and promote the accumulation of hepatic cAMP in the early pre-replicative period, are likely to play a role in the induction of these C/EBP isoforms after PH. The cAMP-dependent kinase, protein kinase A, has also been shown to influence the function of C/EBPβ protein by phosphorylating Ser299 (21Chinery R. Brockman J.A. Dransfield D.T. Coffey R.J. J. Biol. Chem. 1997; 272: 30356-30361Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar). Norepinephrine and other α-adrenergic agents that promote increases in intracellular calcium and activate calmodulin-sensitive kinases in the regenerating liver may also regulate C/EBPβ because there is evidence that Cam kinase II phosphorylation of C/EBPβ alters its DNA binding activity (20Trautwein C. Caelles C. vander Geer P. Hunter T. Karin M. Chojkier M. Nature. 1993; 364: 544-547Crossref PubMed Scopus (293) Google Scholar). Regenerative increases in circulating corticosteroids may contribute to increase the expression of C/EBPδ mRNAs that have been observed in the regenerating liver (63MacDougald O.A. Cornelius P. Lin F.-T. Chen S.S. Lane M.D. J. Biol. Chem. 1994; 269: 19041-19047Abstract Full Text PDF PubMed Google Scholar). Several hepatocyte mitogens that regulate the hepatocyte proliferative response during regeneration (including epidermal growth factor, transforming growth factor α, and HGF) may also influence C/EBP function. These growth factors activate receptor tyrosine kinases that couple to mitogen-activated kinases (64Davis R.J. Mol. Reprod. Dev. 1995; 42: 459-467Crossref PubMed Scopus (383) Google Scholar), which are known to phosphorylate C/EBPβ (65Nakajima T. Kinoshita S. Sasagawa T. Sasaki K. Naruto M. Kishimoto T. Akira S. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 2207-2211Crossref PubMed Scopus (514) Google Scholar). Injury-related cytokines are also likely to play important roles in regulating C/EBP function in the regenerating liver. For example, IL-6 and IL-1β are well established inducers of C/EBPβ and C/EBPδ mRNA expression, respectively (53Alam T. An M.R. Papaconstantinou J. J. Biol. Chem. 1992; 267: 5021-5024Abstract Full Text PDF PubMed Google Scholar), whereas TNFα has been shown to increase the DNA binding activity of C/EBPβ and C/EBPδ by affecting the nuclear localization of these proteins (18Yin M. Yang S.Q. Lin H.Z. Lane M.D. Chatterjee S. Diehl A.M. J. Biol. Chem. 1996; 271: 17974-17978Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar). The latter appears to have physiological relevance for liver regeneration because pretreatment with anti-TNF antibodies inhibits the nuclear accumulation of these C/EBP isoforms and decreases their participation in DNA complex formation after PH (46Diehl A.M. Yang S.Q. Yin M. Lin H.Z. Nelson S. Bagby G. Hepatology. 1995; 22: 252-261PubMed Google Scholar). Thus, many factors that regulate the proliferation and differentiated functions of hepatocytes during the regenerative response are also known to effect the biological activity of the C/EBPs. Given this and the fact that the C/EBPs regulate the proliferation and differentiation of many types of cells, these transcription factors are likely to be important downstream targets for growth factor-initiated signals that drive the regeneration of the liver after it has been injured (Fig. 1). Definitive proof of this concept as well as progress in delineating the relative importance of various C/EBP family members during liver regeneration is now possible by studying the regenerative response to PH in transgenic mice strains with targeted deletion(s) of specific C/EBP genes." @default.
• W2022139626 created "2016-06-24" @default.
• W2022139626 creator A5020766248 @default.
• W2022139626 date "1998-11-01" @default.
• W2022139626 modified "2023-10-11" @default.
• W2022139626 title "Roles of CCAAT/Enhancer-binding Proteins in Regulation of Liver Regenerative Growth" @default.
• W2022139626 cites W1522814938 @default.
• W2022139626 cites W1535914029 @default.
• W2022139626 cites W1553229669 @default.
• W2022139626 cites W1647782814 @default.
• W2022139626 cites W1753632547 @default.
• W2022139626 cites W179818011 @default.
• W2022139626 cites W1813044481 @default.
• W2022139626 cites W1819665821 @default.
• W2022139626 cites W1832181040 @default.
• W2022139626 cites W1931565824 @default.
• W2022139626 cites W1938146920 @default.
• W2022139626 cites W1964842789 @default.
• W2022139626 cites W1969496258 @default.
• W2022139626 cites W1970114925 @default.
• W2022139626 cites W1974937526 @default.
• W2022139626 cites W1980049264 @default.
• W2022139626 cites W1981692093 @default.
• W2022139626 cites W1982017174 @default.
• W2022139626 cites W1983585255 @default.
• W2022139626 cites W1992042790 @default.
• W2022139626 cites W1999448911 @default.
• W2022139626 cites W2007595662 @default.
• W2022139626 cites W2012668445 @default.
• W2022139626 cites W2013282373 @default.
• W2022139626 cites W2022139382 @default.
• W2022139626 cites W2025421728 @default.
• W2022139626 cites W2026591908 @default.
• W2022139626 cites W2032984787 @default.
• W2022139626 cites W2034200840 @default.
• W2022139626 cites W2034856894 @default.
• W2022139626 cites W2034946903 @default.
• W2022139626 cites W2036195205 @default.
• W2022139626 cites W2038912397 @default.
• W2022139626 cites W2043493252 @default.
• W2022139626 cites W2047842452 @default.
• W2022139626 cites W2063679966 @default.
• W2022139626 cites W2078853769 @default.
• W2022139626 cites W2081145901 @default.
• W2022139626 cites W2084122627 @default.
• W2022139626 cites W2085012939 @default.
• W2022139626 cites W2087390102 @default.
• W2022139626 cites W2087423245 @default.
• W2022139626 cites W2089478514 @default.
• W2022139626 cites W2100915449 @default.
• W2022139626 cites W2135855901 @default.
• W2022139626 cites W2153876841 @default.
• W2022139626 cites W2154969618 @default.
• W2022139626 cites W2162134297 @default.
• W2022139626 cites W2162460978 @default.
• W2022139626 cites W2162564085 @default.
• W2022139626 cites W2166431178 @default.
• W2022139626 cites W2166788322 @default.
• W2022139626 cites W2182302387 @default.
• W2022139626 cites W4211173486 @default.
• W2022139626 doi "https://doi.org/10.1074/jbc.273.47.30843" @default.
• W2022139626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9812973" @default.
• W2022139626 hasPublicationYear "1998" @default.
• W2022139626 type Work @default.
• W2022139626 sameAs 2022139626 @default.
• W2022139626 citedByCount "140" @default.
• W2022139626 countsByYear W20221396262012 @default.
• W2022139626 countsByYear W20221396262013 @default.
• W2022139626 countsByYear W20221396262014 @default.
• W2022139626 countsByYear W20221396262016 @default.
• W2022139626 countsByYear W20221396262017 @default.
• W2022139626 countsByYear W20221396262018 @default.
• W2022139626 countsByYear W20221396262021 @default.
• W2022139626 countsByYear W20221396262022 @default.
• W2022139626 countsByYear W20221396262023 @default.
• W2022139626 crossrefType "journal-article" @default.
• W2022139626 hasAuthorship W2022139626A5020766248 @default.
• W2022139626 hasBestOaLocation W20221396261 @default.
• W2022139626 hasConcept C104317684 @default.
• W2022139626 hasConcept C111936080 @default.
• W2022139626 hasConcept C149240914 @default.
• W2022139626 hasConcept C185592680 @default.
• W2022139626 hasConcept C55493867 @default.
• W2022139626 hasConcept C86339819 @default.
• W2022139626 hasConcept C86803240 @default.
• W2022139626 hasConcept C94966510 @default.
• W2022139626 hasConcept C95444343 @default.
• W2022139626 hasConceptScore W2022139626C104317684 @default.
• W2022139626 hasConceptScore W2022139626C111936080 @default.
• W2022139626 hasConceptScore W2022139626C149240914 @default.
• W2022139626 hasConceptScore W2022139626C185592680 @default.
• W2022139626 hasConceptScore W2022139626C55493867 @default.
• W2022139626 hasConceptScore W2022139626C86339819 @default.
• W2022139626 hasConceptScore W2022139626C86803240 @default.
• W2022139626 hasConceptScore W2022139626C94966510 @default.
• W2022139626 hasConceptScore W2022139626C95444343 @default.
• W2022139626 hasIssue "47" @default.
• W2022139626 hasLocation W20221396261 @default.

• next